Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors

Masashi Ueda, Kei Ogawa, Azusa Miyano, Masahiro Ono, Shinae Kizaka-Kondoh, Hideo Saji

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose: We aimed to develop a radiolabeled peptide probe for the imaging of hypoxia-inducible factor-1 (HIF-1)-active tumors. Procedures: We synthesized the peptide probes that contain or lack an essential sequence of the oxygen-dependent degradation of HIF-1α in proteasomes ( 123/125I-DKOP30 or 125I-mDKOP, respectively). The degradation of probes was evaluated in vitro using cell lysates containing proteasomes. In vivo biodistribution study, planar imaging, autoradiography, and comparison between probe accumulation and HIF-1 transcriptional activity were also performed. Results: The 125I-DKOP30 underwent degradation in a proteasome-dependent manner, while 125I-mDKOP was not degraded. Biodistribution analysis showed 125I-DKOP30 accumulation in tumors. The tumors were clearly visualized by in vivo imaging, and intratumoral distribution of 125I-DKOP30 coincided with the HIF-1α-positive hypoxic regions. Tumoral accumulation of 125I-DKOP30 was significantly correlated with HIF-1-dependent luciferase bioluminescence, while that of 125I-mDKOP was not. Conclusion: 123I-DKOP30 is a useful peptide probe for the imaging of HIF-1-active tumors.

Original languageEnglish
Pages (from-to)713-721
Number of pages9
JournalMolecular Imaging and Biology
Volume15
Issue number6
DOIs
Publication statusPublished - Dec 2013
Externally publishedYes

Fingerprint

Hypoxia-Inducible Factor 1
Oxygen
Peptides
Proteasome Endopeptidase Complex
Neoplasms
Luciferases
Autoradiography

Keywords

  • Hypoxia-inducible factor-1
  • Nuclear medical imaging
  • Oxygen-dependent degradation
  • Peptide
  • Tumor hypoxia

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors. / Ueda, Masashi; Ogawa, Kei; Miyano, Azusa; Ono, Masahiro; Kizaka-Kondoh, Shinae; Saji, Hideo.

In: Molecular Imaging and Biology, Vol. 15, No. 6, 12.2013, p. 713-721.

Research output: Contribution to journalArticle

Ueda, Masashi ; Ogawa, Kei ; Miyano, Azusa ; Ono, Masahiro ; Kizaka-Kondoh, Shinae ; Saji, Hideo. / Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors. In: Molecular Imaging and Biology. 2013 ; Vol. 15, No. 6. pp. 713-721.
@article{7f9d534c7a8e4472adb834836671cf50,
title = "Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors",
abstract = "Purpose: We aimed to develop a radiolabeled peptide probe for the imaging of hypoxia-inducible factor-1 (HIF-1)-active tumors. Procedures: We synthesized the peptide probes that contain or lack an essential sequence of the oxygen-dependent degradation of HIF-1α in proteasomes ( 123/125I-DKOP30 or 125I-mDKOP, respectively). The degradation of probes was evaluated in vitro using cell lysates containing proteasomes. In vivo biodistribution study, planar imaging, autoradiography, and comparison between probe accumulation and HIF-1 transcriptional activity were also performed. Results: The 125I-DKOP30 underwent degradation in a proteasome-dependent manner, while 125I-mDKOP was not degraded. Biodistribution analysis showed 125I-DKOP30 accumulation in tumors. The tumors were clearly visualized by in vivo imaging, and intratumoral distribution of 125I-DKOP30 coincided with the HIF-1α-positive hypoxic regions. Tumoral accumulation of 125I-DKOP30 was significantly correlated with HIF-1-dependent luciferase bioluminescence, while that of 125I-mDKOP was not. Conclusion: 123I-DKOP30 is a useful peptide probe for the imaging of HIF-1-active tumors.",
keywords = "Hypoxia-inducible factor-1, Nuclear medical imaging, Oxygen-dependent degradation, Peptide, Tumor hypoxia",
author = "Masashi Ueda and Kei Ogawa and Azusa Miyano and Masahiro Ono and Shinae Kizaka-Kondoh and Hideo Saji",
year = "2013",
month = "12",
doi = "10.1007/s11307-013-0647-6",
language = "English",
volume = "15",
pages = "713--721",
journal = "Molecular Imaging and Biology",
issn = "1536-1632",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors

AU - Ueda, Masashi

AU - Ogawa, Kei

AU - Miyano, Azusa

AU - Ono, Masahiro

AU - Kizaka-Kondoh, Shinae

AU - Saji, Hideo

PY - 2013/12

Y1 - 2013/12

N2 - Purpose: We aimed to develop a radiolabeled peptide probe for the imaging of hypoxia-inducible factor-1 (HIF-1)-active tumors. Procedures: We synthesized the peptide probes that contain or lack an essential sequence of the oxygen-dependent degradation of HIF-1α in proteasomes ( 123/125I-DKOP30 or 125I-mDKOP, respectively). The degradation of probes was evaluated in vitro using cell lysates containing proteasomes. In vivo biodistribution study, planar imaging, autoradiography, and comparison between probe accumulation and HIF-1 transcriptional activity were also performed. Results: The 125I-DKOP30 underwent degradation in a proteasome-dependent manner, while 125I-mDKOP was not degraded. Biodistribution analysis showed 125I-DKOP30 accumulation in tumors. The tumors were clearly visualized by in vivo imaging, and intratumoral distribution of 125I-DKOP30 coincided with the HIF-1α-positive hypoxic regions. Tumoral accumulation of 125I-DKOP30 was significantly correlated with HIF-1-dependent luciferase bioluminescence, while that of 125I-mDKOP was not. Conclusion: 123I-DKOP30 is a useful peptide probe for the imaging of HIF-1-active tumors.

AB - Purpose: We aimed to develop a radiolabeled peptide probe for the imaging of hypoxia-inducible factor-1 (HIF-1)-active tumors. Procedures: We synthesized the peptide probes that contain or lack an essential sequence of the oxygen-dependent degradation of HIF-1α in proteasomes ( 123/125I-DKOP30 or 125I-mDKOP, respectively). The degradation of probes was evaluated in vitro using cell lysates containing proteasomes. In vivo biodistribution study, planar imaging, autoradiography, and comparison between probe accumulation and HIF-1 transcriptional activity were also performed. Results: The 125I-DKOP30 underwent degradation in a proteasome-dependent manner, while 125I-mDKOP was not degraded. Biodistribution analysis showed 125I-DKOP30 accumulation in tumors. The tumors were clearly visualized by in vivo imaging, and intratumoral distribution of 125I-DKOP30 coincided with the HIF-1α-positive hypoxic regions. Tumoral accumulation of 125I-DKOP30 was significantly correlated with HIF-1-dependent luciferase bioluminescence, while that of 125I-mDKOP was not. Conclusion: 123I-DKOP30 is a useful peptide probe for the imaging of HIF-1-active tumors.

KW - Hypoxia-inducible factor-1

KW - Nuclear medical imaging

KW - Oxygen-dependent degradation

KW - Peptide

KW - Tumor hypoxia

UR - http://www.scopus.com/inward/record.url?scp=84890478073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890478073&partnerID=8YFLogxK

U2 - 10.1007/s11307-013-0647-6

DO - 10.1007/s11307-013-0647-6

M3 - Article

C2 - 23689986

AN - SCOPUS:84890478073

VL - 15

SP - 713

EP - 721

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

IS - 6

ER -